WMT

111.44

-0.41%↓

COST

861.88

-0.43%↓

TGT

97.78

+0.34%↑

KR

62.53

-0.24%↓

DG.US

132.74

-2.24%↓

WMT

111.44

-0.41%↓

COST

861.88

-0.43%↓

TGT

97.78

+0.34%↑

KR

62.53

-0.24%↓

DG.US

132.74

-2.24%↓

WMT

111.44

-0.41%↓

COST

861.88

-0.43%↓

TGT

97.78

+0.34%↑

KR

62.53

-0.24%↓

DG.US

132.74

-2.24%↓

WMT

111.44

-0.41%↓

COST

861.88

-0.43%↓

TGT

97.78

+0.34%↑

KR

62.53

-0.24%↓

DG.US

132.74

-2.24%↓

WMT

111.44

-0.41%↓

COST

861.88

-0.43%↓

TGT

97.78

+0.34%↑

KR

62.53

-0.24%↓

DG.US

132.74

-2.24%↓

Search

Afya Ltd (Class A)

Cerrado

SectorConsumo defensivo

15.41 2.66

Resumen

Variación precio

24h

Actual

Mínimo

14.91

Máximo

15.49

Métricas clave

By Trading Economics

Ingresos

-13M

181M

Ventas

9.1M

929M

P/B

Media del Sector

10.29

28.154

Rentabilidad por dividendo

1.56

Margen de beneficios

19.455

EBITDA

-28M

397M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+31.14% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.56%

3.65%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

40M

1.4B

Apertura anterior

12.75

Cierre anterior

15.41

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

54 / 147 Clasificación en Consumer defensive

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Afya Ltd (Class A) Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

31 dic 2025, 22:20 UTC

Principales Movimientos del Mercado

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

31 dic 2025, 17:31 UTC

Principales Movimientos del Mercado

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

31 dic 2025, 16:30 UTC

Principales Movimientos del Mercado

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

31 dic 2025, 15:19 UTC

Principales Movimientos del Mercado

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

31 dic 2025, 15:17 UTC

Principales Movimientos del Mercado

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

31 dic 2025, 14:37 UTC

Principales Movimientos del Mercado

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

31 dic 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

31 dic 2025, 21:13 UTC

Adquisiciones, fusiones, absorciones

10 People to Watch in Wealth Management in 2026 -- Barrons.com

31 dic 2025, 20:40 UTC

Charlas de Mercado

Dollar Posting Its Worst Year Since 2017 -- Market Talk

31 dic 2025, 20:22 UTC

Charlas de Mercado

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

31 dic 2025, 19:50 UTC

Charlas de Mercado

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

31 dic 2025, 19:31 UTC

Charlas de Mercado

Precious Metals Cap Off Record Runs -- Market Talk

31 dic 2025, 18:50 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

31 dic 2025, 18:50 UTC

Charlas de Mercado

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

31 dic 2025, 17:17 UTC

Charlas de Mercado

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

31 dic 2025, 17:16 UTC

Principales Movimientos del Mercado

OwlTing Climbs on Launch of $10M Stock-Buyback Program

31 dic 2025, 17:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

31 dic 2025, 17:00 UTC

Adquisiciones, fusiones, absorciones

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

31 dic 2025, 15:57 UTC

Adquisiciones, fusiones, absorciones

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

31 dic 2025, 15:54 UTC

Charlas de Mercado

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

31 dic 2025, 15:02 UTC

Principales Movimientos del Mercado

Nike Shares Rise After CEO Hill Buys $1M of Shares

31 dic 2025, 14:40 UTC

Adquisiciones, fusiones, absorciones

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

31 dic 2025, 14:20 UTC

Charlas de Mercado

Crude Futures On Track to End the Year With Losses -- Market Talk

31 dic 2025, 13:46 UTC

Charlas de Mercado

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

31 dic 2025, 13:01 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Charles Schwab Is Back on Offense. Its Stock Is a Buy. -- Barrons.com

31 dic 2025, 11:10 UTC

Charlas de Mercado

Copper Remains in Touching Distance of Record Highs -- Market Talk

31 dic 2025, 10:46 UTC

Charlas de Mercado

Euro on Track For Strong Annual Performance -- Market Talk

31 dic 2025, 10:25 UTC

Charlas de Mercado

European Gas Prices Rise But Remain on Track for Heavy Annual Loss -- Market Talk

31 dic 2025, 10:23 UTC

Charlas de Mercado

Chinese Yuan Rises to 31-Month High Against Dollar as Policymakers -- Market Talk

31 dic 2025, 09:33 UTC

Charlas de Mercado

Dollar Set For Worst Annual Performance Since 2017 -- Market Talk

Comparación entre iguales

Cambio de precio

Afya Ltd (Class A) previsión

Precio Objetivo

By TipRanks

31.14% repunte

Estimación a 12 Meses

Media 19.75 USD  31.14%

Máximo 22 USD

Mínimo 17.5 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Afya Ltd (Class A) Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

1

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

18.968 / 19.56Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Strong Bullish Evidence

Sentimiento

By Acuity

54 / 147 Clasificación en Consumo defensivo

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Afya Ltd (Class A)

Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
help-icon Live chat